William Blair & Company’s Lunai Bioworks LNAI Stock Holding History

William Blair & Company’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-201	Closed	-$4.65K	–	1895
2025 Q2	$4.65K	Hold	201	–	–	﹤0.01%	1769
2025 Q1	$8.75K	Hold	201	–	–	﹤0.01%	1720
2024 Q4	$13.5K	Hold	201	–	–	﹤0.01%	1710
2024 Q3	$7.78K	Hold	201	–	–	﹤0.01%	1765
2024 Q2	$28.2K	Hold	201	–	–	﹤0.01%	1661
2024 Q1	$42.7K	Hold	201	–	–	﹤0.01%	1617
2023 Q4	$51K	Sell	201 -124	-38%	-$34K	﹤0.01%	1577
2023 Q3	$116K	Hold	325	–	–	﹤0.01%	1482
2023 Q2	$14.7K	Hold	325	–	–	﹤0.01%	1708
2023 Q1	$23.8K	Hold	325	–	–	﹤0.01%	1673
2022 Q4	$26.8K	Hold	325	–	–	﹤0.01%	1650
2022 Q3	$47K	Buy	325 +87	+37%	+$15.9K	﹤0.01%	1601
2022 Q2	$37K	Buy	238 +38	+19%	+$17.4K	﹤0.01%	1661
2022 Q1	$132K	Sell	200 -13	-6%	-$6.92K	﹤0.01%	1600
2021 Q4	$124K	Hold	213	–	–	﹤0.01%	1663
2021 Q3	$114K	Buy	+213	New	+$104K	﹤0.01%	1597

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

William Blair & Company's LNAI Position: Q3 2025 in Review

William Blair & Company sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 201 shares — an estimated $4.65K sold.

William Blair & Company first reported a position in LNAI in Q3 2021 and held it in 16 quarters. The position peaked at $132K in Q1 2022. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

William Blair & Company reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
William Blair & Company sold 201 Lunai Bioworks shares in Q3 2025, an estimated $4.65K.
William Blair & Company first reported a position in Lunai Bioworks in Q3 2021 and held it in 16 quarters.
William Blair & Company's Lunai Bioworks position peaked at $132K in Q1 2022.
20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on William Blair & Company's 13F filing for Q3 2025, filed 12 Nov 2025.